Molecular Characterization of Microrna Interference and Aristolochic Acid Intoxication Found in Upper Tract Urothelial Carcinoma in Patients with Balkan Endemic Nephropathy: A Systematic Review of the Current Literature

1. Polenakovic M, Stefanovic V. Balkan nephropathy. In: Cameron J. S., Davison A. M., Grunfeld J. P., Kerr D., Ritz E., editors. Oxford Textbook of Clinical Nephrology. 1st. Oxford, UK: Oxford University Press; 1992. pp. 857–866. Polenakovic M Stefanovic V . Balkan nephropathy . In: Cameron J. S. Davison A. M. Grunfeld J. P. Kerr D. Ritz E. editors. Oxford Textbook of Clinical Nephrology. 1st. Oxford, UK : Oxford University Press ; 1992 . pp. 857 – 866 . Search in Google Scholar

2. Djukanović L, Radovanović Z. Balkan endemic nephropathy. In: De Broe M. E., Porter G. A., Bennett W. M., Verpooten G. A., editors. Clinical Nephrotoxins. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2003. pp. 587–601. Djukanović L Radovanović Z. Balkan endemic nephropathy . In: De Broe M. E. Porter G. A. Bennett W. M. Verpooten G. A. editors. Clinical Nephrotoxins. Dordrecht, The Netherlands : Kluwer Academic Publishers ; 2003 . pp. 587 – 601 . Search in Google Scholar

3. Stefanovic V, Radovanovic Z. Balkan endemic nephropathy and associated urothelial cancer. Nature Clinical Practice Urology. 2008;5(2):105–112. Stefanovic V Radovanovic Z . Balkan endemic nephropathy and associated urothelial cancer . Nature Clinical Practice Urology. 2008 ; 5 ( 2 ): 105 – 112 . Search in Google Scholar

4. Stefanovic V. Current status and research beyond year 2010 in Balkan endemic nephropathy. BANTAO Journal. 2009;7(2):4–9. Stefanovic V . Current status and research beyond year 2010 in Balkan endemic nephropathy . BANTAO Journal. 2009 ; 7 ( 2 ): 4 – 9 . Search in Google Scholar

5. Stefanovic V, Polenakovic M, Toncheva D. Urothelial carcinoma associated with Balkan endemic nephropathy. A worldwide disease. Pathologie Biologie. 2011;59(5):286–291. Stefanovic V Polenakovic M Toncheva D . Urothelial carcinoma associated with Balkan endemic nephropathy. A worldwide disease . Pathologie Biologie. 2011 ; 59 ( 5 ): 286 – 291 . Search in Google Scholar

6. Polenakovic M, Stefanović V. What do we know about the Balkan endemic nephropathy and the uroepithelial tumors? Prilozi. 2014;35(1):11–15. Polenakovic M Stefanović V . What do we know about the Balkan endemic nephropathy and the uroepithelial tumors? Prilozi. 2014 ; 35 ( 1 ): 11 – 15 . Search in Google Scholar

7. Velickovic L. J, Hattori T, Stefanovic V. Molecular markers in upper urothelial carcinoma associated to Balkan endemic nephropathy. Aristolochic acid as the major risk factor of the worldwide disease. The-ScientificWorldJournal. 2009;9: 1360–1373. Velickovic L. J Hattori T Stefanovic V . Molecular markers in upper urothelial carcinoma associated to Balkan endemic nephropathy. Aristolochic acid as the major risk factor of the worldwide disease . The-ScientificWorldJournal. 2009 ; 9 : 1360 – 1373 . Search in Google Scholar

8. Toncheva D, Dimitrov T, Stojanova S. Etiology of Balkan endemic nephropathy: a multifactorial disease? European Journal of Epidemiology. 1998;14(4):389–394. Toncheva D Dimitrov T Stojanova S . Etiology of Balkan endemic nephropathy: a multifactorial disease? European Journal of Epidemiology. 1998 ; 14 ( 4 ): 389 – 394 . Search in Google Scholar

9. Ivic M. The problem of etiology of endemic nephropathy. Lijecnicki Vjesnik. 1969;91: 1278–1281. Ivic M . The problem of etiology of endemic nephropathy . Lijecnicki Vjesnik. 1969 ; 91 : 1278 – 1281 . Search in Google Scholar

10. De Broe M. E. Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy. Kidney International. 2012;81(6):513–515. De Broe M. E. Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy . Kidney International. 2012 ; 81 ( 6 ): 513 – 515 . Search in Google Scholar

11. Vanherweghem J.-. Depierreux M, Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. The Lancet. 1993;341(8842):387–391. Vanherweghem J.-. Depierreux M Tielemans C Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs . The Lancet. 1993 ; 341 ( 8842 ): 387 – 391 . Search in Google Scholar

12. Nortier J. L, Martinez M.-C. M, Schmeiser H. H, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fang chi) The New England Journal of Medicine. 2000;342(23):1686–1692. Nortier J. L Martinez M.-C. M Schmeiser H. H Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fang chi) The New England Journal of Medicine. 2000 ; 342 ( 23 ): 1686 – 1692 . Search in Google Scholar

13. Vanhaelen M, Vanhaelen-Fastre R, But P, Vanherweghem J.-L. Identification of aristolochic acid in Chinese herbs. The Lancet. 1994;343(8890):p. 174. Vanhaelen M Vanhaelen-Fastre R But P Vanherweghem J.-L. Identification of aristolochic acid in Chinese herbs . The Lancet. 1994 ; 343 ( 8890 ):p. 174 . Search in Google Scholar

14. Yang C.-S, Lin C.-H, Chang S.-H, Hsu H.-C. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. American Journal of Kidney Diseases. 2000;35(2):313–318. Yang C.-S Lin C.-H Chang S.-H Hsu H.-C. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs . American Journal of Kidney Diseases. 2000 ; 35 ( 2 ): 313 – 318 . Search in Google Scholar

15. Chang C.-H, Wang Y.-M, Yang A.-H, Chiang S.-S. Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications. American Journal of Nephrology. 2001;21(6):441–448. Chang C.-H Wang Y.-M Yang A.-H Chiang S.-S. Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications . American Journal of Nephrology. 2001 ; 21 ( 6 ): 441 – 448 . Search in Google Scholar

16. Lord G. M, Cook T, Arlt V. M, Schmeiser H. H, Williams G, Pusey C. D. Urothelial malignant disease and Chinese herbal nephropathy. The Lancet. 2001;358(9292):1515–1516. Lord G. M Cook T Arlt V. M Schmeiser H. H Williams G Pusey C. D. Urothelial malignant disease and Chinese herbal nephropathy . The Lancet. 2001 ; 358 ( 9292 ): 1515 – 1516 . Search in Google Scholar

17. Li X.-B, Xing N.-Z, Wang Y, Hu X.-P, Yin H, Zhang X.-D. Transitional cell carcinoma in renal transplant recipients: a single center experience. International Journal of Urology. 2008;15(1):53–57. Li X.-B Xing N.-Z Wang Y Hu X.-P Yin H Zhang X.-D. Transitional cell carcinoma in renal transplant recipients: a single center experience . International Journal of Urology. 2008 ; 15 ( 1 ): 53 – 57 . Search in Google Scholar

18. Cosyns J, Jadoul M, Squifflet J.-P, Van Cangh P, van Ypersele de Strihou C. Urothelial malignancy innephropathy due to Chinese herbs. Lancet 1994, 344, 188. Cosyns J Jadoul M Squifflet J.-P Van Cangh P van Ypersele de Strihou C . Urothelial malignancy innephropathy due to Chinese herbs . Lancet 1994 , 344 , 188 . Search in Google Scholar

19. Nortier J.L, Martinez Muniz M.-C, Schmeiser H.H, Arlt V.M, Bieler C.A, Petein, M, Depierreux, M.F, de Pauw L, Abramowicz D, Vereerstraeten P, et al. Urothelial carcinoma associated with the use of a Chinese herb. N. Engl. J. Med. 2000, 342, 1686–1692. Nortier J.L Martinez Muniz M.-C Schmeiser H.H Arlt V.M Bieler C.A Petein M Depierreux M.F de Pauw L Abramowicz D Vereerstraeten P Urothelial carcinoma associated with the use of a Chinese herb . N. Engl. J. Med. 2000 , 342 , 1686 – 1692 . Search in Google Scholar

20. World Health Organization. Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans; IARC Press: Lyon, France, 2002; Volume 82. World Health Organization . Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene . In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans ; IARC Press : Lyon, France , 2002 ; Volume 82 . Search in Google Scholar

21. Debelle F.D, Vanherweghem J.-L, and Nortier J.L. Aristolochic acid nephropathy: A worldwide problem. Kidney Int. 2008, 74, 158–169. Debelle F.D Vanherweghem J.-L Nortier J.L. Aristolochic acid nephropathy: A worldwide problem . Kidney Int. 2008 , 74 , 158 – 169 . Search in Google Scholar

22. Chen C.-H, Dickman K.G, Moriya M, Zavadil J, Sidorenko V.S, Edwards K.L, Gnatenko D.V, Wu L, Turesky R.J, Wu X.-R, et al. Aristolochic acidassociated urothelial cancer in Taiwan. Proc. Natl. Acad. Sci. USA 2012, 109, 8241–8246. Chen C.-H Dickman K.G Moriya M Zavadil J Sidorenko V.S Edwards K.L Gnatenko D.V Wu L Turesky R.J Wu X.-R Aristolochic acidassociated urothelial cancer in Taiwan . Proc. Natl. Acad. Sci. USA 2012 , 109 , 8241 – 8246 . Search in Google Scholar

23. Schmeiser H.H, Janssen J.W.G, Lyons J, Scherf H.R, Pfau W, Buchmann A, Bartram C.R, Wiessler M. Aristolochic Acid Activates ras Genes in Rat Tumors at Deoxyadenosine Residues. Cancer Res. 1990, 50, 5464–5469. Schmeiser H.H Janssen J.W.G Lyons J Scherf H.R Pfau W Buchmann A Bartram C.R Wiessler M. Aristolochic Acid Activates ras Genes in Rat Tumors at Deoxyadenosine Residues . Cancer Res. 1990 , 50 , 5464 – 5469 . Search in Google Scholar

24. Lord G.M, Hollstein M, Arlt V.M, Roufosse C, Pusey C.D, Cook T, Schmeiser H.H. DNA adducts and p53 mutations in a patient with aristolochic acidassociated nephropathy. Am. J. Kidney Dis. 2004, 43,e18.1–e18.7. Lord G.M Hollstein M Arlt V.M Roufosse C Pusey C.D Cook T Schmeiser H.H. DNA adducts and p53 mutations in a patient with aristolochic acidassociated nephropathy . Am. J. Kidney Dis. 2004 , 43 , e18.1 – e18.7 . Search in Google Scholar

25. Hollstein M, Moriya M, Grollman A.P, Olivier M. Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental caecinogen Hollstein M, Moriya M, Grollman A.P, Olivier Hollstein M Moriya M Grollman A.P Olivier M. Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental caecinogen Hollstein M, Moriya M, Grollman A.P, Olivier Search in Google Scholar

26. Arlt V.M, Stiborova M, Schmeiser H.H. Aristolochic acid as a probable human cancer hazard in herbal remedies: A review. Mutagenesis 2002, 17, 265–277 Arlt V.M Stiborova M Schmeiser H.H. Aristolochic acid as a probable human cancer hazard in herbal remedies: A review . Mutagenesis 2002 , 17 , 265 – 277 Search in Google Scholar

27. Slade N, Moll U.M, Brdar B, Zori´c A, Jelakovi´c B. p53 mutations as fingerprints for aristolochic acid— An environmental carcinogen in endemic (Balkan) nephropathy. Mutat. Res. Fundam. Mol. Mech. Mutagen. 2009,663, 1–6. Slade N Moll U.M Brdar B Zori´c A Jelakovi´c B . p53 mutations as fingerprints for aristolochic acid— An environmental carcinogen in endemic (Balkan) nephropathy . Mutat. Res. Fundam. Mol. Mech. Mutagen. 2009 , 663 , 1 – 6 . Search in Google Scholar

28. Hoang M.L, Chen C.-H, Sidorenko V.S, He J, Dickman K.G, Yun B.H, Moriya M, Niknafs N, Douville C, Karchin R, et al. Mutational Signature of Aristolochic Acid Exposure as Revealed by Whole Exome sequencing.Sci.Trans.Med.2013,5. Hoang M.L Chen C.-H Sidorenko V.S He J Dickman K.G Yun B.H Moriya M Niknafs N Douville C Karchin R Mutational Signature of Aristolochic Acid Exposure as Revealed by Whole Exome sequencing . Sci.Trans.Med. 2013 , 5 . Search in Google Scholar

29. Moriya M, Slade N, Brdar B, Medverec Z, Tomic K, Jelakovi´c B, Wu L,Truong S, Fernandes A, Grollman A.P. TP53 Mutational signature for aristolochic acid: An environmental carcinogen. Int. J. Cancer 2011, 129, 1532–1536. Moriya M Slade N Brdar B Medverec Z Tomic K Jelakovi´c B Wu L Truong S Fernandes A Grollman A.P. TP53 Mutational signature for aristolochic acid: An environmental carcinogen . Int. J. Cancer 2011 , 129 , 1532 – 1536 . Search in Google Scholar

30. Aydin S, Dekairelle A.-F, Ambroise J, Durant J.-F, Heusterspreute M, Cosyns Y.G.J.-P, Gala J.-L. Unambiguous Detection of Multiple TP53 Gene Mutations in AAN-Associated Urothelial Cancer in Belgium Using Laser Capture Microdissection. PLoS ONE 2014, 9, e106301. Aydin S Dekairelle A.-F Ambroise J Durant J.-F Heusterspreute M Cosyns Y.G.J.-P Gala J.-L. Unambiguous Detection of Multiple TP53 Gene Mutations in AAN-Associated Urothelial Cancer in Belgium Using Laser Capture Microdissection . PLoS ONE 2014 , 9 , e106301 . Search in Google Scholar

31. Wang Y, Meng F, Arlt VM, Mei N, Chen T, Parsons BL. Aristolochic acid-induced carcinogenesis examined by ACB-PCR quantification of H-Ras and KRas mutant fraction. Mutagenesis. 2011;26: 619–628. Wang Y Meng F Arlt VM Mei N Chen T Parsons BL . Aristolochic acid-induced carcinogenesis examined by ACB-PCR quantification of H-Ras and KRas mutant fraction . Mutagenesis. 2011 ; 26 : 619 – 628 . Search in Google Scholar

32. Olivier M, Hollstein M, Schmeiser HH, Straif K, Wild CP. Upper urinary tract urothelial cancer: where it is A: T. Nat Rev. 2012;12: 503–504. Olivier M Hollstein M Schmeiser HH Straif K Wild CP . Upper urinary tract urothelial cancer: where it is A: T . Nat Rev. 2012 ; 12 : 503 – 504 . Search in Google Scholar

33. Poon SL, Pang ST, McPherson JR, et al. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool. Sci Transl Med 2013;5: 197ra101. Poon SL Pang ST McPherson JR Genome-wide mutational signatures of aristolochic acid and its application as a screening tool . Sci Transl Med 2013 ; 5 : 197ra101 . Search in Google Scholar

34. Simmons D. Epigenetic influence and disease. Nature Education. 2008;1(1, article 6) Simmons D . Epigenetic influence and disease . Nature Education . 2008 ; 1 (1, article 6) Search in Google Scholar

35. Staneva R, Rukova B, Hadjidekova S, et al. Whole genome methylation array analysis reveals new aspects in Balkan endemic nephropathy etiology. BMC Nephrology. 2013;14, article 225 Staneva R Rukova B Hadjidekova S Whole genome methylation array analysis reveals new aspects in Balkan endemic nephropathy etiology . BMC Nephrology . 2013 ; 14 , article 225 Search in Google Scholar

36. Kocic G, Cukuranovic J, Stoimenov T. J., et al. Global and specific histone acetylation pattern in patients with Balkan endemic nephropathy, a worldwide disease. Renal Failure. 2014;36(7):1078–1082. Kocic G Cukuranovic J Stoimenov T. J. Global and specific histone acetylation pattern in patients with Balkan endemic nephropathy, a worldwide disease . Renal Failure. 2014 ; 36 ( 7 ): 1078 – 1082 . Search in Google Scholar

37. Neely L. A., Rieger-Christ K. M., Neto B. S., et al. A microRNA expression ratio defining the invasive phenotype in bladder tumors. Urologic Oncology: Seminars and Original Investigations. 2010;2 8(1):39–48. Neely L. A. Rieger-Christ K. M. Neto B. S. A microRNA expression ratio defining the invasive phenotype in bladder tumors . Urologic Oncology: Seminars and Original Investigations. 2010 ; 28 ( 1 ): 39 – 48 . Search in Google Scholar

38. Wang G, Zhang H, He H, et al. Up-regulation of microRNA in bladder tumor tissue is not common. International Urology and Nephrology. 2010;42(1):95–102. Wang G Zhang H He H Up-regulation of microRNA in bladder tumor tissue is not common . International Urology and Nephrology. 2010 ; 42 ( 1 ): 95 – 102 . Search in Google Scholar

39. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001;294(5543):853–858. Lagos-Quintana M Rauhut R Lendeckel W Tuschl T . Identification of novel genes coding for small expressed RNAs . Science. 2001 ; 294 ( 5543 ): 853 – 858 . Search in Google Scholar

40. Bartel D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297. Bartel D. P. MicroRNAs: genomics, biogenesis, mechanism, and function . Cell. 2004 ; 116 ( 2 ): 281 – 297 . Search in Google Scholar

41. Alvarez-Garcia I, Miska E. A. MicroRNA functions in animal development and human disease. Development. 2005;132(21):4653–4662. Alvarez-Garcia I Miska E. A. MicroRNA functions in animal development and human disease . Development. 2005 ; 132 ( 21 ): 4653 – 4662 . Search in Google Scholar

42. Calin G. A, Sevignani C, Dumitru C. D, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(9):2999–3004. Calin G. A Sevignani C Dumitru C. D Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers . Proceedings of the National Academy of Sciences of the United States of America. 2004 ; 101 ( 9 ): 2999 – 3004 . Search in Google Scholar

43. Nikolova D, Toncheva D. RNA interferenceregulations and application in oncology. Journal of Cancer Molecules. 2008;4(3):67–77. Nikolova D Toncheva D . RNA interferenceregulations and application in oncology . Journal of Cancer Molecules. 2008 ; 4 ( 3 ): 67 – 77 . Search in Google Scholar

44. Kent O. A, Mendell J. T. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene. 2006;25(46):6188–6196. Kent O. A Mendell J. T. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes . Oncogene. 2006 ; 25 ( 46 ): 6188 – 6196 . Search in Google Scholar

45. Gottardo F, Liu C. G, Ferracin M, et al. MicroRNA profiling in kidney and bladder cancers. Urologic Oncology: Seminars and Original Investigations. 2007;25(5):387–392. Gottardo F Liu C. G Ferracin M MicroRNA profiling in kidney and bladder cancers . Urologic Oncology: Seminars and Original Investigations. 2007 ; 25 ( 5 ): 387 – 392 . Search in Google Scholar

46. Lu J, Getz G, Miska E. A, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834–838. Lu J Getz G Miska E. A MicroRNA expression profiles classify human cancers . Nature. 2005 ; 435 ( 7043 ): 834 – 838 . Search in Google Scholar

47. Stenvang J, Silahtaroglu A. N, Lindow M, Elmen J, Kauppinen S. The utility of LNA in microRNAbased cancer diagnostics and therapeutics. Seminars in Cancer Biology. 2008;18(2):89–102. Stenvang J Silahtaroglu A. N Lindow M Elmen J Kauppinen S . The utility of LNA in microRNAbased cancer diagnostics and therapeutics . Seminars in Cancer Biology. 2008 ; 18 ( 2 ): 89 – 102 . Search in Google Scholar

48. Tao L, Zeng Y, Wang J, et al. Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo. Molecular Medicine Reports. 2015;12(5):6533–6546. Tao L Zeng Y Wang J Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo . Molecular Medicine Reports. 2015 ; 12 ( 5 ): 6533 – 6546 . Search in Google Scholar

49. Meng F, Li Z, Yan J, et al. Tissue-specific microRNA responses in rats treated with mutagenic and carcinogenic doses of aristolochic acid. Mutagenesis. 2014;29(5):357–365. Meng F Li Z Yan J Tissue-specific microRNA responses in rats treated with mutagenic and carcinogenic doses of aristolochic acid . Mutagenesis. 2014 ; 29 ( 5 ): 357 – 365 . Search in Google Scholar

50. Wang Y.-Y, Li Z, Chen T, Zhao X.-M. Understanding the aristolochic acid toxicities in rat kidneys with regulatory networks. IET Systems Biology. 2015;9(4):141–146. Wang Y.-Y Li Z Chen T Zhao X.-M. Understanding the aristolochic acid toxicities in rat kidneys with regulatory networks . IET Systems Biology. 2015 ; 9 ( 4 ): 141 – 146 . Search in Google Scholar

51. Popovska-Jankovic K, Noveski P, JankovicVelickovic Lj, Stojnev S, Cukuranovic R, Stefanovic V, Toncheva D, Staneva R, Polenakovic M, PlaseskaKaranfilska D. MicroRNA Profiling in Patients with Upper Tract Urothelial Carcinoma Associated with Balkan Endemic Nephropathy. Biomed Res Int. 2016: 7450461. Popovska-Jankovic K Noveski P JankovicVelickovic Lj Stojnev S Cukuranovic R Stefanovic V Toncheva D Staneva R Polenakovic M PlaseskaKaranfilska D . MicroRNA Profiling in Patients with Upper Tract Urothelial Carcinoma Associated with Balkan Endemic Nephropathy . Biomed Res Int. 2016 : 7450461 . Search in Google Scholar

52. Wei S, Yao Y, Gupta P. K, Bing Z. miRNA expression in lower and upper urothelial carcinoma and the potential clinical application. Proceedings of the 102nd United States and Canadian Academy of Pathology Annual Meeting (USCAP ‘13); March 2013; Baltimore, Md, USA. Baltimore Convention Center. Wei S Yao Y Gupta P. K Bing Z . miRNA expression in lower and upper urothelial carcinoma and the potential clinical application . Proceedings of the 102nd United States and Canadian Academy of Pathology Annual Meeting (USCAP ‘13) ; March 2013 ; Baltimore, Md, USA . Baltimore Convention Center . Search in Google Scholar

53. Blick C, Ramachandran A, Wigfield S, McCormick R, Jubb A, Buffa FM, et al. Hypoxia regulates FGFR3 expression via HIF-1alpha and miR100 and contributes to cell survival in non-muscle invasive bladder cancer. Br J Cancer. 2013; 109 (1):509. Blick C Ramachandran A Wigfield S McCormick R Jubb A Buffa FM Hypoxia regulates FGFR3 expression via HIF-1alpha and miR100 and contributes to cell survival in non-muscle invasive bladder cancer . Br J Cancer. 2013 ; 109 ( 1 ): 509 . Search in Google Scholar

54. Ratert N, Meyer HA, Jung M, Mollenkopf HJ, Wagner I, Miller K, Kilic E, Erbersdobler A, Weikert S, Jung K. Reference miRNAs for miRNAome analysis of urothelial carcinomas. PLoS One. 2012; 7:e39309. Ratert N Meyer HA Jung M Mollenkopf HJ Wagner I Miller K Kilic E Erbersdobler A Weikert S Jung K . Reference miRNAs for miRNAome analysis of urothelial carcinomas . PLoS One. 2012 ; 7 : e39309 . Search in Google Scholar

55. Wu C.F, Pang S.T, Shee J.J, Chang P.L, Chuang C.K, Chen C.S, Liao S.K, Weng W.H. Identification of genetic alterations in upper urinary tract urothelial carcinoma in end-stage renal disease patients. Genes Chromosomes Cancer 2010, 49, 928–934. Wu C.F Pang S.T Shee J.J Chang P.L Chuang C.K Chen C.S Liao S.K Weng W.H. Identification of genetic alterations in upper urinary tract urothelial carcinoma in end-stage renal disease patients . Genes Chromosomes Cancer 2010 , 49 , 928 – 934 . Search in Google Scholar

56. Kurataka O and Takahiro O. Genetic Networks Lead and Follow Tumor Development: MicroRNA Regulation of Cell Cycle and Apoptosis in the p53 Pathways. Biomed Res Int. 2014; 2014: 749724. Kurataka O Takahiro O . Genetic Networks Lead and Follow Tumor Development: MicroRNA Regulation of Cell Cycle and Apoptosis in the p53 Pathways . Biomed Res Int. 2014 ; 2014 : 749724 . Search in Google Scholar

57. Munekazu Yamakuchi. MicroRNA Regulation of SIRT1. Front Physiol. 2012; 3: 68. Yamakuchi Munekazu . MicroRNA Regulation of SIRT1 . Front Physiol. 2012 ; 3 : 68 . Search in Google Scholar

58. Pramanik D, Campbell N. R, Karikari C, Chivukula R, Kent O. A, Mendell J. T, Maitra A. Restitution of tumor suppressor microRNAs using a systemic nano vector inhibits pancreatic cancer growth in mice. Mol. Cancer Ther. 2011; 10, 1470–1480. Pramanik D Campbell N. R Karikari C Chivukula R Kent O. A Mendell J. T Maitra A . Restitution of tumor suppressor microRNAs using a systemic nano vector inhibits pancreatic cancer growth in mice . Mol. Cancer Ther. 2011 ; 10 , 1470 – 1480 . Search in Google Scholar

59. Pogribny I P, Muskhelishvili L, Tryndyak V. P, Beland F. A. The tumor-promoting activity of 2acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation. Toxicol. Appl. Pharmacol. 2009; 235, 305–311. Pogribny I P Muskhelishvili L Tryndyak V. P Beland F. A. The tumor-promoting activity of 2acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation . Toxicol. Appl. Pharmacol. 2009 ; 235 , 305 – 311 . Search in Google Scholar

60. Yunshu Y,Yang L, Yunwei W, Yongyi Ch, Jinxin Zh, Yanhui J, Jun T, Dahai H. Regulation of SIRT1 and Its Roles in Inflammation. Front Immunol. 2022; 13: 831168. Yunshu Y Yang L Yunwei W Yongyi Ch Jinxin Zh Yanhui J Jun T Dahai H . Regulation of SIRT1 and Its Roles in Inflammation . Front Immunol. 2022 ; 13 : 831168 . Search in Google Scholar

61. Ivic N. The problem of etiology of endemic nephropathy. Lijecnicki Vjesnik. 1969; 91: 1278–1281. Ivic N . The problem of etiology of endemic nephropathy . Lijecnicki Vjesnik. 1969 ; 91 : 1278 – 1281 . Search in Google Scholar

62. Pavlović Nikola. Balkan endemic nephropathy—current status and future perspectives. Clinical Kidney Journal. 2013; 257–26. Nikola Pavlović . Balkan endemic nephropathy—current status and future perspectives . Clinical Kidney Journal . 2013 ; 257 – 26 . Search in Google Scholar

63. Jadot I,Declèves A, Nortier J, Caron N. An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature. Int. J. Mol. Sci. 2017; 18(2), 297. Jadot I Declèves A Nortier J Caron N . An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature . Int. J. Mol. Sci. 2017 ; 18 ( 2 ), 297 . Search in Google Scholar